Rapid Rx Quiz: Opioids

Mary L. Windle, PharmD


July 08, 2022

Concurrent MAOI use or use within 14 days of MAOI therapy is one of the contraindications to tapentadol use, owing to risk for serotonin syndrome. Tapentadol is a mu-opioid receptor agonist and a norepinephrine reuptake inhibitor. Other contraindications include acute or severe asthma, gastrointestinal obstruction, and significant respiratory depression. Although oxycodone, hydromorphone, and methadone should be used with caution in patients with recent MAOI use, they are not contraindicated.

Learn more about warnings for tapentadol.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.